RTW Venture Fund Ltd (RTW) - Cash Flow Conversion Efficiency
Based on the latest financial reports, RTW Venture Fund Ltd (RTW) has a cash flow conversion efficiency ratio of 0.052x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($30.70 Million) by net assets ($585.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see RTW company net worth for the company's overall valuation and market capitalisation.
RTW Venture Fund Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how RTW Venture Fund Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
RTW Venture Fund Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RTW Venture Fund Ltd ranked by their cash flow conversion efficiency. Explore RTW Venture Fund Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nanjing Kangni Mechanical & Electrical Co Ltd
SHG:603111
|
0.013x |
|
HomeTrust Bancshares, Inc.
NYSE:HTB
|
0.187x |
|
INDIA SHELTER FINANCE CORPORATION LIMITED
NSE:INDIASHLTR
|
-0.149x |
|
Grupo Posadas S.A.B. de C.V
MX:POSADASA
|
0.097x |
|
Fujian Foxit Software Development Joint Stock Co Ltd
SHG:688095
|
0.024x |
|
Eagle Bancorp Inc
NASDAQ:EGBN
|
-0.030x |
|
Pan-International Industrial Corp
TW:2328
|
0.044x |
|
Winnebago Industries Inc
NYSE:WGO
|
-0.020x |
Annual Cash Flow Conversion Efficiency for RTW Venture Fund Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of RTW Venture Fund Ltd from 2017 to 2025. View RTW Venture Fund Ltd stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $865.22 Million | $105.25 Million | 0.122x | +161.90% |
| 2024-12-31 | $632.64 Million | $-124.34 Million | -0.197x | -351.39% |
| 2023-12-31 | $429.02 Million | $33.54 Million | 0.078x | +273.56% |
| 2022-12-31 | $347.92 Million | $-15.67 Million | -0.045x | +61.12% |
| 2021-12-31 | $387.36 Million | $-44.87 Million | -0.116x | -341.06% |
| 2020-12-31 | $412.61 Million | $-10.84 Million | -0.026x | +91.49% |
| 2019-12-31 | $214.39 Million | $-66.16 Million | -0.309x | -45702.90% |
| 2018-12-31 | $65.72 Million | $-44.28K | -0.001x | +99.78% |
| 2017-12-31 | $37.80 Million | $-11.71 Million | -0.310x | -- |
About RTW Venture Fund Ltd
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patien… Read more